An evaluation of antimicrobial efficacy of acnano against some acne causing microorganisms

International Journal of Drug Development and Research

Volumn 2, Issue 1, 2010, Pages 134-140

  Naithani, Vijay ^a   Kumar, Shailesh ^a   Srivastava, Mohan Sanjay ^a   Pathak, Naveen ^a   Chaudhary, Manu ^a  

^a Venus Medicine Research Centre   (India)

Author keywords

Acnano; Antibacterial susceptibility; Pacnes; Saureus; Sepidermidis

Indexed keywords

ACNANO; ANTI ACNE AGENT; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ACNE; AGAR DIFFUSION; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CITROBACTER; CITROBACTER BRAAKII; DRUG EFFICACY; DRUG SCREENING; DRUG SENSITIVITY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MICROORGANISM; MORGANELLA MORGANII; NONHUMAN; PROPIONIBACTERIUM; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SACCHAROMYCES CEREVISIAE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 77954515406     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Alexis AF, Lamb A. Concomitant therapy for acne in patients with skin of color: a case-based approach. Dermatol Nurs 2009; 21(1): 33-36.
2. Lolis MS, Bowe WP, Shalita AR. Acne and systemic disease. Med Clin North Am 2009; 93(6): 1161-1181.
3. Ramos-e-Silva M, Carneiro SC. Acne vulgaris: review and guidelines. Dermatol Nurs 2009; 21(2): 63-68.
4. Bowe WP, Shalita AR. Effective over-the-counter acne treatments. Semin Cutan Med Surg 2008; 27: 170.
5. Ghali F, Kang S, Leyden J, Shalita AR, Thiboutot DM. Changing the face of acne therapy. Cutis 2009; 83(2 Suppl): 4-15.
6. Nakatsuji T, Kao MC, Fang JY, Zouboulis CC, Zhang L, Gallo RL, Huang CM. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol 2009; 129(10): 2480-2488
7. Pechère M, Germanier L, Siegenthaler G, Pechère JC, Saurat JH. The antibacterial activity of topical retinoids: the case of retinaldehyde. Dermatology 2002; 205(2): 153-158
8. Yamaguchi N, Satoh-Yamaguchi K, Ono M. In vitro evaluation of antibacterial, anticollagenase, and antioxidant activities of hop components (Humulus lupulus) addressing acne vulgaris. Phytomedicine 2009; 16(4): 369-376.
9. Swanson JK. Antibiotic Resistance of Propionibacterium acnes in Acne Vulgaris. Dermatology Nursing 2003; 15(4):
10. Bachmeyer C, Landgraf N, Cordier F, Lemaitre P, Blum L. Acinetobacter baumanii folliculitis in a patient with AIDS. Clin Exp Dermatol 2005; 30(3): 256-258.
11. Boni R, Nehrhoff B. Treatment of gram-negative folliculitis in patients with acne. Am J Clin Dermatol 2003; 4(4): 273-276.
12. Gupta R, Rauf SJ, Singh S, Smith J, Agraharkar ML. Sepsis in a renal transplant recipient due to Citrobacter braakii. South Med J 2003; 96(8): 796-798.
13. Isaac-Márquez AP, Lezama-Dávila CM. Detection of pathogenic bacteria in skin lesions of patients with chiclero's ulcer. Reluctant response to antimonial treatment. Mem Inst Oswaldo Cruz 2003; 98(8): 1093-1095.
14. Kwakman PH, Van den Akker JP, Güçlü A, Aslami H, Binnekade JM, de Boer L, Boszhard L, Paulus F, Middelhoek P, te Velde AA, Vandenbroucke-Grauls CM, Schultz MJ, Zaat SA. Medical-grade honey kills antibiotic-resistant bacteria in vitro and eradicates skin colonization. Clin Infect Dis 2008; 46(11): 1677-1682.
15. Leyden JJ, McGinley KJ, Mills OH. Pseudomonas aeruginosa gram-negative folliculitis. Arch Dermatol 1979; 115(10): 1203-1204.
16. Papadopoulos CJ, Carson CF, Hammer KA, Riley TV. Susceptibility of pseudomonads to Melaleuca alternifolia (tea tree) oil and components. J Antimicrob Chemother 2006; 58(2): 449-451.
17. Samonis G, Karageorgopoulos DE, Kofteridis DP, Matthaiou DK, Sidiropoulou V, Maraki S, Falagas ME. Citrobacter infections in a general hospital: characteristics and outcomes. Eur J Clin Microbiol Infect Dis 2009; 28(1): 61-68.
18. Hammer KA, Carson CF, Riley TV. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. J Antimicrob Chemother 2004; 53(6): 1081-1085
19. Kishore N, Mishra AK, Chansouria JP. Fungitoxicity of essential oils against dermatophytes. Mycoses 1993; 36(5-6): 211-215
20. Mohapatra S, Xess I, Swetha JV, Tanveer N, Asati D, Ramam M, Singh MK. Primary cutaneous aspergillosis due to Aspergillus niger in an immunocompetent patient. Indian J Med Microbiol 2009; 27(4): 367-370
21. Williams JS, Mufti GJ, Powell S, Salisbury JR, Higgins EM. Saccharomyces cerevisiae emboli in an immuno-compromised patient with relapsed acute myeloid leukaemia. Clin Exp Dermatol 2007; 32(4): 395-397
22. Yehia MA, El-Ammawi TS, Al-Mazidi KM, Abu El-Ela MA, Al-Ajmi HS. The Spectrum of Fungal Infections with a Special Reference to Dermatophytoses in the Capital Area of Kuwait During 2000-2005: A Retrospective Analysis. Mycopathologia 2009